Thomas W. Geisbert, Ph.D.
Affiliations: | 2003 | Uniformed Services University of the Health Sciences, Bethesda, MD |
Area:
Animal Pathology Agriculture, Microbiology Biology, PathologyGoogle:
"Thomas Geisbert"Parents
Sign in to add mentor| Elliott Kagan | grad student | 2003 | Uniformed Services University | |
| (Pathogenesis of ebola hemorrhagic fever in primate models in vivo and in vitro.) | ||||
Collaborators
Sign in to add collaborator| James Earl Crowe, Jr. | collaborator | University of Texas at Galveston Medical Branch (ID Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cross RW, Woolsey C, Chu VC, et al. (2024) Oral administration of obeldesivir protects nonhuman primates against . Science (New York, N.Y.). 383: eadk6176 |
| Cross RW, Fenton KA, Woolsey C, et al. (2024) Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus. Cell Reports. Medicine. 101392 |
| To A, Wong TAS, Ball AH, et al. (2023) Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine |
| Cross RW, Wiethoff CM, Brown-Augsburger P, et al. (2023) The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms. Pathogens (Basel, Switzerland). 12 |
| Pigeaud DD, Geisbert TW, Woolsey C. (2023) Animal Models for Henipavirus Research. Viruses. 15 |
| Mire CE, Satterfield BA, Geisbert TW. (2023) Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation. Methods in Molecular Biology (Clifton, N.J.). 2682: 159-173 |
| Satterfield BA, Mire CE, Geisbert TW. (2023) Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus Infection. Methods in Molecular Biology (Clifton, N.J.). 2682: 1-22 |
| Cross RW, Fenton KA, Foster SL, et al. (2023) Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence between Angola and Ci67 strains. The Journal of Infectious Diseases |
| Bushmaker T, Feldmann F, Lovaglio J, et al. (2023) Limited benefit of post-exposure prophylaxis with VSV-EBOV in Ebola virus-infected rhesus macaques. The Journal of Infectious Diseases |
| Fletcher P, O'Donnell KL, Doratt BM, et al. (2023) Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infection. Emerging Microbes & Infections. 12: 2239950 |